Saturday 17 October 2026 Export ANIK’s income statement to Excel — free account

Anika Therapeutics Inc.

ANIK Healthcare Drug Manufacturers Specialty & Generic

Anika Therapeutics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $112.8 million, down 5.91% from fiscal 2024. In the quarter to June 2026, revenue grew 15.6%, EPS grew 189.3% and free cash flow grew 61.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

19.98 0.71 −3.43%

Follow ANIK

Alert me

Market cap: $276.9M
P/E: 0.0×
Fwd P/E: −20.0×
Dividend yield: —
F-score: 6/9
Altman Z: 3.13
Beneish M: −2.84
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		1.20	1.22	1.69	1.62
P/FCF ratio Full definition →		108.60	27.77	0.00	347.01
P/Operating CF Full definition →		19.73	29.72	(40.49)	(285.11)
P/B ratio Full definition →		0.92	0.96	1.47	1.42
Price to Tangible BV Full definition →		0.99	1.03	1.58	1.53
EV/Sales Full definition →		0.91	0.93	1.55	1.51
EV/EBITDA Full definition →		0.00	0.00	0.00	354.70
EV/Operating CF Full definition →		12.61	9.41	27.84	30.38
EV/FCF Full definition →		82.17	21.22	(63.07)	323.14
Quick Ratio Full definition →		4.20	3.71	3.19	3.05
Current Ratio Full definition →		5.32	4.72	4.46	4.48
Net Debt/EBITDA Full definition →		31.69	(29.27)	10.05	(8.61)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.54	0.57	0.63	0.65
Operating CF/Net income Full definition →		(2.95)	15.88	0.96	(0.21)
Capex/Depreciation Full definition →		(1.34)	(0.49)	(1.02)	(0.96)
Research and Development Expense of Revenue Full definition →		24.97%	21.07%	22.67%	22.51%
Selling, General and Administrative Expense of Revenue Full definition →		42.68%	39.46%	60.02%	33.58%
Intangible Assets out of Total Assets Full definition →		0.05	0.05	0.05	0.05
Share Based Compensation of Revenue Full definition →		7.96%	8.03%	22.43%	5.62%
Graham Net Nets Full definition →		0.44	0.41	0.25	0.27
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(24.26%)	(7.91%)	(5.45%)	(1.78%)
Free Cash Flow Yield Full definition →		0.92%	3.60%	(1.46%)	0.29%
Revenue per Share Full definition →		1.93	2.14	2.19	2.45
Operating CF per Share Full definition →		0.48	0.32	(0.36)	(0.05)
Capex per Share Full definition →		(0.13)	(0.05)	(0.11)	(0.11)
Free Cash Flow per Share Full definition →		0.35	0.28	(0.46)	(0.16)
Cash per Share Full definition →		4.02	4.01	3.03	2.88
Shareholders Equity per Share Full definition →		10.18	10.01	9.90	10.30
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		10.18	10.01	9.90	10.30
Free Cash Flow Full definition →		4.98	3.99	(6.28)	(2.13)
Working Capital Full definition →		82.50	81.45	72.60	77.04
Capital Expenditures Full definition →		(1.89)	(0.65)	(1.43)	(1.45)
Net Current Asset Value Full definition →		58.96	56.55	48.08	53.00
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.07	0.02	0.05	0.04
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		25.27	23.64	23.88	26.51
Average Payables Full definition →		5.77	5.83	5.81	5.50
Average Inventory Full definition →		27.96	21.30	22.09	22.74
Average Assets Full definition →		210.42	196.51	185.00	185.58
Average Common Equity Full definition →		163.33	148.73	141.15	142.48

Fold the line items

Columns are period end dates

Stockrow Weekly